Breaking News - The Fly

Open Search

ARGX

Argenx

$

()

Argenx presents data from ADHERE trial evaluating Vyvgart Hytrulo

ARGX

4/16/2024 - 05:33am

Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call

ARGX

4/10/2024 - 11:09am

Immunovant initiated with bullish view at Oppenheimer, here's why

IMVT , ARGX

3/27/2024 - 16:07pm

Argenx advances clinical development of efgartigimod

ARGX

3/27/2024 - 05:21am

Argenx price target raised by $6 at Scotiabank, here's why

ARGX

3/26/2024 - 07:58am

Argenx announces MHLW approval of Vyvgart

ARGX

3/26/2024 - 05:26am

Roche’s mixed myasthenia gravis data sending these stocks in opposite directions

RHHBY , TRML , ARGX

…

3/21/2024 - 10:54am

Immunovant rallies after Chugai myasthenia gravis study failure

IMVT , RHHBY , ARGX

3/21/2024 - 08:12am

Argenx rallies after Chugai generalized myasthenia gravis study fails

ARGX , RHHBY

3/21/2024 - 07:15am

Argenx price target raised by EUR 12 at Morgan Stanley

ARGX

3/15/2024 - 14:54pm

Argenx price target lowered by EUR 20 at JPMorgan

ARGX

3/5/2024 - 14:55pm

Argenx price target raised by $70 at Truist, here's why

ARGX

3/5/2024 - 07:13am

Argenx price target raised by $10 at Guggenheim, here's why

ARGX

3/1/2024 - 07:50am

Argenx price target raised by $56 at Scotiabank, here's why

ARGX

3/1/2024 - 07:08am

Argenx price target lowered by $15 at Baird, here's why

ARGX

3/1/2024 - 06:45am